Daniel Alexander Yerace serves as Executive at Coeptis Therapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Daniel Alexander Yerace has executed 1 insider transactions totaling $7.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 5, 2024 involved purchasing 10,850 shares valued at $7.5K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 5, 2024 | COEP | $7.5K | Purchase | 10,850 | $0.69 | Discretionary |
Daniel Alexander Yerace currently holds 1,071,455 shares of Coeptis Therapeutics Holdings, Inc. (COEP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Alexander Yerace has been a net buyer of COEP stock. They have purchased $7.5K and sold $0 worth of shares.
Daniel Alexander Yerace's most recent insider trade was on Jan 5, 2024, when they purchased 10,850 shares at $0.69 per share.
Get notified when new Form 4 filings are submitted